ELITEK J Code: J2783

Drug & Product Overview

HCPCS Descriptor Injection, rasburicase, 0.5 mg

HCPCS Added Date January 1, 2004

Manufacturer Sanofi

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Kit

About ELITEK

Elitek is a medication aligned to the HCPCS J Code: J2783 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by Sanofi.

According to CMS Drug Use Information: This medication is used to prevent high blood levels of uric acid from occurring in children with cancer (such as leukemia, lymphoma, solid malignant tumors) who are about to receive cancer chemotherapy treatment. When chemotherapy is given, cancer cells are destroyed, releasing large amounts of uric acid into the bloodstream. This medication allows uric acid to more easily be removed from the body by the kidneys.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
00024-5150-10	Elitek	Sanofi-Aventis U.S. LLC	9	Kit
00024-5151-75	Elitek	Sanofi-Aventis U.S. LLC	15	Kit

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

ELITEK Pricing & Reimbursement

J2783 Private Payer Reimbursement

$394.13 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q4 2026

ELITEK CPT Administration Codes

CPT Code	Description
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)

JW / JZ modifiers apply

CMS has identified Elitek (J2783) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

ELITEK Medically Unlikely Edits (MUE)

The most billing units of J2783 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 0.5 mg.

Practitioner Office & Hospital Outpatient

60 units / day

= 30 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

ELITEK Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

leukemia, lymphoma, and solid tumor malignancies

Frequently Asked Questions

Is there an available Elitek billing and coding guide?

Billing and coding information for ELITEK can be found through Sanofi. Visit Here →

Are there any available Elitek patient assistance programs?

ELITEK patient assistance information can be found through Sanofi. Visit Here →

Where can I find Elitek prescribing information?

ELITEK prescribing information can be found at the link below: Visit Here →

Where can I find Elitek side effect information?

Information regarding ELITEK's side effects can be found at MedlinePlus Visit Here →

Does billing ELITEK require JZ/JW wastage modifiers?

CMS has identified ELITEK(J2783) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.